Commerzbank's Upward Trajectory Hits a Regulatory Speed Bump as BaFin Probes UniCredit's Disclosure
08.06.2026 - 14:44:34 | boerse-global.de
The battle for Commerzbank just got a fresh layer of complexity. Germany's financial watchdog BaFin has stepped in to examine whether UniCredit overstated its grip on the lender's equity. The Italian bank had signalled it could command access to more than 50% of Commerzbank shares through a combination of directly held stock, derivatives and already tendered paper. Frankfurt's counter-narrative is blunt: that portrayal is misleading, and the market may have been distorted.
Investors reacted by shaving 1.36% off the share price on Monday, leaving it at €36.32. Yet the broader twelve-month picture remains emphatic — a 29.58% gain that few other European bank stocks can match. The pullback is modest against a backdrop of operational momentum that few analysts dispute.
Commerzbank's first quarter of 2026 delivered an operating record of €1.358 billion, underpinned by higher net profit and a growing fee pool even as net interest income held steady. Management used that strength to lift the 2026 net profit floor to €3.4 billion. The board then unveiled "Momentum 2030" in May, targeting an ambitious 21% return on tangible equity and a cost-income ratio of 43% by the decade's end. For 2028 the intermediate goals are a net result of €4.6 billion and an ROE of roughly 17%. A planned €600 million artificial-intelligence investment by 2030 is expected to yield an extra €500 million in annual value-add from that point onwards.
Should investors sell immediately? Or is it worth buying Commerzbank?
Against that self-help story sits UniCredit's tender offer — and the market is underwhelmed. The proposal swaps 0.485 UniCredit shares for each Commerzbank share, implying a current value of roughly €35.50 to €36.00. Since the freely traded stock fetches more, the incentive to tender is minimal. Data from Commerzbank show only 7.6% of shareholders have accepted the exchange, and among retail investors the figure is a wafer-thin 0.05%. CEO Andrea Orcel faces a widening credibility gap: an offer priced below the market rarely wins hearts.
Technically, the stock remains in solid shape. It trades above all key moving averages, with a 9.5% buffer to the 200-day line — a sign of trend strength rather than froth. The relative strength index sits at 56.4, comfortably below overbought territory. The distance to the 52-week high of €38.15, touched on June 1, is a mere 4.80%. That gap, together with the fundamental upgrades, leaves room for optimism even as the regulatory drama unfolds.
Both sides now face two pivotal dates. On June 10 the European Central Bank delivers its next rate decision, which will reshape earnings expectations for lenders across the continent. Then on June 16 the tender deadline falls; if UniCredit does not improve its terms before then, the low acceptance rate will become a strategic liability. Commerzbank, meanwhile, keeps pressing its case for autonomy. It paid out a €1.10 dividend in May and argues that an independent path — backed by a 21% ROE target and concrete delivery — offers shareholders more value than a vague, below-market bid. BaFin's verdict on UniCredit's disclosure could tilt the calculus one way or the other.
Ad
Commerzbank Stock: New Analysis - 8 June
Fresh Commerzbank information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Commerzbanks Aktien ein!
FĂĽr. Immer. Kostenlos.
